Poliomyelitis Vaccine Market: How Is the Global Switch from OPV to IPV and Novel OPV2 Reshaping Eradication Strategy?
Poliomyelitis eradication — the global immunization program reducing wild poliovirus cases from 350,000 annually in 1988 to fewer than ten cases in recent years — stands at a critical inflection point where vaccine-derived poliovirus has become the predominant transmission threat, with the Poliomyelitis Vaccine Market reflecting the transition from oral poliovirus vaccine dominance...
0 Comments 0 Shares 248 Views 0 Reviews
Sponsored
Sponsored